1. insights
  2. newsletters
  3. the executive edge

The Executive Edge

The Executive Edge: December 10, 2025

Subscription Required
Graphic featuring a lightbulb icon and the text “Executive Edge” against a blue and white patterned background, representing a branded content series.

Contact Us to Gain Access
Newsletter | Executive Insight HubWHOOP(s)! The FDA’s Crackdown on Wearables

Wearables are entering a stricter regulatory era. FDA’s WHOOP warning shows that clinical-like features won’t pass as wellness. The ripple effects — and how industry partners should respond.

Subscription Required
The Conversation Starter: New Biosimilar Rules Shake the Drug Market

Contact Us to Gain Access
Newsletter | Executive Insight HubThe Conversation Starter: New Biosimilar Rules Shake the Drug Market

FDA Drops Trial Requirements for Biosimilars, Reshaping Drug Costs

Subscription Required
Graphic featuring a lightbulb icon and the text “Executive Edge” against a blue and white patterned background, representing a branded content series.

Contact Us to Gain Access
Newsletter | Executive Insight HubCVS to Pay Nearly $38M on Claims Over Insulin Pens

CVS’ $38M insulin-pen settlement signals rising scrutiny on medication dispensing, documentation, and billing accuracy across the healthcare industry.

Subscription Required
Graphic featuring a lightbulb icon and the text “Executive Edge” against a blue and white patterned background, representing a branded content series.

Contact Us to Gain Access
Newsletter | Executive Insight HubCMS Finalizes 2026 Home Health Payment Rule: What Industry Partners Need to Know

How CMS’s 2026 Home Health Rule Will Reshape Discharges, Equity Measures, and the Future of Care at Home